AI Article Synopsis

  • The study investigates the occurrence of external compression of the outflow graft (eOGO) in patients with HeartMate 3 left ventricular assist devices (LVAD), finding a prevalence of 3.0% among 2108 patients over several years of support.
  • Data showed that while eOGO is rare, its incidence increases over time, reaching 9.1% by the fifth year of LVAD support.
  • Clinical outcomes for patients with eOGO included various interventions, with a mortality rate of 17.0% after therapeutic intervention, highlighting the importance of early detection and management.

Article Abstract

Background: The HeartMate 3 (HM 3; Abbott) left ventricular assist device (LVAD) has improved hemocompatibility-related adverse outcomes. In sporadic cases, external compression of the outflow graft causing obstruction (eOGO) can result from substance accumulation between the outflow graft and its bend relief. We sought to evaluate the prevalence, course, and clinical implications of eOGO in an international study.

Methods: A multicenter retrospective analysis of HM 3 LVADs implanted between November 2014 and April 2021 (n = 2108) was conducted across 17 cardiac centers in 8 countries. We defined eOGO as obstruction >25% in the cross-sectional area in imaging (percutaneous angiography, computed tomography, or intravascular ultrasound). The prevalence and annual incidence were calculated. Serious adverse events and outcomes (death, transplantation, or device exchange) were analyzed for eOGO cases.

Results: Of 2108 patients, 62 were diagnosed with eOGO at a median LVAD support duration of 953 (interquartile range, 600-1267) days. The prevalence of eOGO was 3.0% and the incidence at 1, 2, 3, 4, and 5 years of support was 0.6%, 2.8%, 4.0%, 5.2%, and 9.1%, respectively. Of 62 patients, 9 were observed, 27 underwent surgical revision, 15 underwent percutaneous stent implantation, 8 received a heart transplant, and 2 died before intervention. One patient underwent surgical revision and later stent implantation. The mortality with therapeutic intervention was 9/53 (17.0%).

Conclusions: Although uncommon, HM 3 LVAD-supported patients might develop eOGO with an increasing incidence after 1 year of support. Although engineering efforts to reduce this complication are under way, clinicians must maintain a focus on early detection and remain vigilant.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtcvs.2022.09.051DOI Listing

Publication Analysis

Top Keywords

outflow graft
12
left ventricular
8
ventricular assist
8
assist device
8
underwent surgical
8
surgical revision
8
stent implantation
8
eogo
7
multicenter evaluation
4
evaluation external
4

Similar Publications

Objective: Diffuse coronary artery disease remains a critical issue that heart surgeons continue to research in terms of treatment options. An alternative method applied during coronary bypass surgery to achieve complete revascularization is coronary artery endarterectomy. Since the reliability of this technique and its effects on mortality and morbidity are still debated in the literature.

View Article and Find Full Text PDF

Alternatives for exhausted dialysis access.

Semin Vasc Surg

December 2024

Department of Surgery, Division of Vascular and Endovascular Surgery, Duke University Medical Center, Durham, NC. Electronic address:

Hemodialysis (HD) access failure is a frequent problem encountered by vascular surgeons. As treatment of end-stage renal disease improves and patients live longer on HD, eventual exhaustion of traditional upper extremity HD access is common. Efforts to preserve and maintain these accesses are essential.

View Article and Find Full Text PDF

Management of thrombosed or failed dialysis access.

Semin Vasc Surg

December 2024

Division of Vascular and Endovascular Surgery, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA, Boston Medical Center, 88 East Newton Street, Boston, MA 02118. Electronic address:

Hemodialysis (HD) access for patients with end-stage renal disease is a steadily increasing necessity, and maintaining patency of native or synthetic fistulas can be challenging. The main physiologic changes of an HD access that cause it to fail are inflow or outflow vessel stenosis or access thrombosis. These are propagated by factors intrinsic to end-stage renal disease, altered hemodynamics from a fistula, and typically further exacerbated by associated comorbidities.

View Article and Find Full Text PDF

Merging mixed reality and computational modeling for enhanced visualization of cardiac biomechanics.

Med Eng Phys

December 2024

Department of Engineering, Università degli Studi di Palermo, Viale delle Scienze Ed.8, Palermo, Italy; Department of Research, IRCCS ISMETT via Tricomi, 5, Palermo, Italy. Electronic address:

Mixed reality (MR) has the potential to complement numerical simulations for enhanced post-processing and integrate digital models into the daily clinical practice of healthcare professionals. In complex cardiac anatomies, the decision-making process for bioprosthesis implantation involves the challenging analysis of heart valve distribution, positioning, and sealing. This study proposes a framework to visualize computational modeling results in an immersive environment for comprehensive analysis of the geometric implications of implanted devices on human heart function.

View Article and Find Full Text PDF

Objective: To compare early patency and outcomes of single outflow (SOT) and double outflow (DOT) reconstruction in right lobe living donor liver transplantation (RtLDLT) in a multicenter open-labelled randomized controlled trial.

Summary Background Data: Optimum graft venous outflow is a key factor in determining outcomes of RtLDLT. There is no data directly comparing SOT and DOT technique of graft outflow reconstruction.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!